Structural basis for the inhibition of HTLV-1 integration inferred from cryo-EM deltaretroviral intasome structures
Autor: | Xue Zhi Zhao, Goedele N. Maertens, Nora B. Cronin, Terrence R. Burke, Stephen H. Hughes, Michal S. Barski, Valerie E. Pye, Teresa Vanzo, Allison Ballandras-Colas, Peter Cherepanov, Steven J. Smith |
---|---|
Přispěvatelé: | Wellcome Trust |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Cryo-electron microscopy
viruses Science General Physics and Astronomy Article General Biochemistry Genetics and Molecular Biology law.invention 03 medical and health sciences Retrovirus Cryoelectron microscopy law medicine 030304 developmental biology 0303 health sciences Multidisciplinary Bictegravir biology 030306 microbiology Chemistry Active site General Chemistry biology.organism_classification Raltegravir Virology In vitro Deltaretrovirus 3. Good health Recombinant DNA biology.protein medicine.drug |
Zdroj: | Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021) Nature Communications |
ISSN: | 2041-1723 |
Popis: | Between 10 and 20 million people worldwide are infected with the human T-cell lymphotropic virus type 1 (HTLV-1). Despite causing life-threatening pathologies there is no therapeutic regimen for this deltaretrovirus. Here, we screened a library of integrase strand transfer inhibitor (INSTI) candidates built around several chemical scaffolds to determine their effectiveness in limiting HTLV-1 infection. Naphthyridines with substituents in position 6 emerged as the most potent compounds against HTLV-1, with XZ450 having highest efficacy in vitro. Using single-particle cryo-electron microscopy we visualised XZ450 as well as the clinical HIV-1 INSTIs raltegravir and bictegravir bound to the active site of the deltaretroviral intasome. The structures reveal subtle differences in the coordination environment of the Mg2+ ion pair involved in the interaction with the INSTIs. Our results elucidate the binding of INSTIs to the HTLV-1 intasome and support their use for pre-exposure prophylaxis and possibly future treatment of HTLV-1 infection. Human T-cell lymphotropic virus type 1 (HTLV-1) is an oncogenic deltaretrovirus. Here the authors provide structural characterization of the binding mechanism of novel integrase strand transfer inhibitor (INSTI) candidates to limit HTLV-1 infection. |
Databáze: | OpenAIRE |
Externí odkaz: |